Get started
Author

Nuria Jiménez

Observed names: N Jimenez, N Jiménez, N. Jiménez
ORCID: 0000-0003-0043-0556
Observed ORCID: 0000-0003-0043-0556
OpenAlex ID: A5047829942
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study
2021 · María Chaparro, Ana Garre, et al. · Journal of Clinical Medicine · 106
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study
2022 · María Chaparro, Iria Baston-Rey, et al. · Inflammatory Bowel Diseases · 70
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain
2019 · María Chaparro, Manuel Barreiro-de Acosta, et al. · Therapeutic Advances in Gastroenterology · 24
Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu
2021 · María José García, Montserrat Rivero, et al. · Journal of Clinical Medicine · 22
Cuff-assisted versus cap-assisted colonoscopy for adenoma detection: results of a randomized study
2019 · Javier Sola-Vera, Lourdes Catalá, et al. · Endoscopy · 21
Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study
2022 · Maria Pilar Ballester, Francisco Mesonero, et al. · Alimentary Pharmacology & Therapeutics · 18
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
2022 · María Chaparro, Iria Baston-Rey, et al. · Journal of Clinical Medicine · 11
Real‐World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry
2026 · M. Iborra, B. Botella, et al. · United European Gastroenterology Journal · 6
Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection
2021 · Alejandro Hernández Camba, Laura Ramos, et al. · Gastroenterología y Hepatología · 6
Impact of Prior Biologic Mechanism of Action on Anti‐ TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study
2026 · Carmen Yagüe Caballero, Santiago García López, et al. · Alimentary Pharmacology & Therapeutics · 4
PDF
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885
2022 · María Chaparro, Ana Garre, et al. · Journal of Clinical Medicine · 4
P391 The availability of anti-TNF agents is associated with reduced early surgical requirements in Crohn’s disease but not in ulcerative colitis. A nationwide study from the Eneida registry
2018 · M Guasch, A Clos, et al. · Journal of Crohn s and Colitis · 4
P0890 Real-World Outcomes of Upadacitinib in Crohn’s Disease: Insights from ENEIDA database
2025 · M Iborra, B Botella, et al. · Journal of Crohn s and Colitis · 1
Factores Predictores Del Uso De Tratamientos Biológicos O Pequeñas Moléculas, Cirugías Y Hospitalizaciones En Una Cohorte De Pacientes Recién Diagnosticados De Eii: Resultados a Largo Plazo Del Estudio Epidemibd De Geteccu
2025 · Ana Garre Vázquez, Andrea Núñez Ortiz, et al. · Gastroenterología y Hepatología · 1
P185 Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain
2021 · A Hernandez Camba, L Ramos, et al. · Journal of Crohn s and Colitis · 1
PDF
P606 Adherence to endoscopic surveillance guidelines for advanced lesions and colorectal cancer in Inflammatory Bowel Disease in Spain: a collaborative study of AEG and GETECCU
2021 · M P Ballester Ferré, F Mesonero, et al. · Journal of Crohn s and Colitis · 1
PDF
P397 Effectiveness of vedolizumab (VDZ) for the induction of remission in inflammatory bowel disease (IBD): Results from the Spanish Eneida Registry
2018 · M Chaparro, A Garre, et al. · Journal of Crohn s and Colitis · 1
Clinical Course and Predictors of Biologic Therapy, Hospitalisation and Surgery: A Five‐Year Prospective Study in Newly Diagnosed Inflammatory Bowel Disease
2026 · Ana Garre, Andrea Nuñez Ortiz, et al. · Alimentary Pharmacology & Therapeutics
Fístula Úlcero-Diverticular Duodenal: Un Simulador Infrecuente de Microperforación en la Hemorragia Digestiva Alta.
2026 · María Pacheco, Enrique Rueda, et al. · Congreso Nacional de la Sociedad Española de Endoscopia Digestiva (SEED)
NaviCam SB con lectura asistida por inteligencia artificial frente a PillCam SB3 con lectura convencional para el estudio del intestino delgado: estudio comparativo NAVIPILL
2026 · Antonio Giordano, Miquel Urpí, et al. · Congreso Nacional de la Sociedad Española de Endoscopia Digestiva (SEED)
Efectividad Del Uso De Un Fármaco Anti-tnf Tras Otro Con Un Mecanismo De Acción Diferente: Evidencia De Práctica Clínica Del Registro Eneida
2026 · Diego Casas Deza, Carmen Yagüe Caballero, et al. · Gastroenterología y Hepatología
P0664 Effectiveness and safety of upadacitinib in ulcerative colitis in clinical practice: results from the U-REAL-UC study from ENEIDA
2025 · M Chaparro, S Hermida, et al. · Journal of Crohn s and Colitis
PDF
P0226 Postoperative recurrence after a definitive ostomy in Crohn's disease. A nationwide retrospective series from the Eneida registry
2025 · M Calafat Sard, M Mañosa, et al. · Journal of Crohn s and Colitis
P-29 - Efectividad De Upadacitinib En La Enfermedad De Crohn: Experiencia Inicial En Vida Real Desde La Base De Datos Eneida
2025 · Marisa Iborra, Belén Botella, et al. · Gastroenterología y Hepatología
Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection
2022 · Alejandro Hernández Camba, Laura Ramos, et al. · Gastroenterología y Hepatología (English Edition)
PDF
Works count: 28
Citation count: 301
H-index: 7
I10-index: 7
Year
Topic
Type